Instruments

Name Stock exchange Average volume Price Type
PETER WARREN AUTOMOTIVE HOLDINGS LIMITED PWR

Australian S.E.

148,834 2.16 AUD Stock Peter Warren Automotive Holdings Limited Stock
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX STOCK PICKING NACH PETER LYNCH

Börse Stuttgart

- 189.7 EUR Certificat ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX STOCK PICKING NACH PETER LYNCH Certificat
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX STOCK PICKING NACH PETER LYNCH LS9CVN

Berne S.E.

- - CHF Certificat ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX STOCK PICKING NACH PETER LYNCH Certificat

News (91)

Worldline: A 'customer first' approach can get British rail back on track AQ
DD: SCHOTT Pharma AG & Co. KGaA: Peter Goldschmidt, buy EQ
Hundreds demonstrate against MSC Group's entry into HHLA DP
Dpa-AFX Overview: ENTERPRISES as of Aug. 15, 2023 - 3:15 p.m. DP
Alvotech : BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. THE OMISSIONS HAVE BEEN INDICATED BY “”. TERMINATION AGREEMENT - Form 6-K PU
Exclusive-Germany's Stada asks Berlin to help secure its future in Ukraine RE
STADA and Xbrane launch ranibizumab to support patient access in Europe AQ
Stada benefits from wave of illnesses and strong Russian business DP
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Aquaporin’s shares AQ
Transcript : Sonic Healthcare Limited - Shareholder/Analyst Call
STADA and Xbrane secure EU approval for Ximluci® (ranibizumab) biosimilar referencing Lucentis® AQ
EMA Adopts Positive Opinion For STADA And Xbrane's Ranibuzumab Biosimilar Candidate XIMLUCI® AQ
Calliditas partner STADA launches the first medicine authorized in the EU for treating primary IgA nephropathy AQ
Calliditas' partner STADA launches the first medicine authorized in the EU for treating primary IgA nephropathy AQ
STADA and Xbrane welcome EMA positive opinion for ranibizumab biosimilar candidate Ximluci AQ
Transcript : MedinCell S.A., 2022 Earnings Call, Jun 14, 2022
Oaktree Acquisition II : Press Release, dated April 6, 2022 - Form 8-K PU
Alvotech and STADA Pave Way to Launching HUKYNDRA®(AVT02), a Citrate-free, High-concentration Biosimilar to Humira® by Resolving European Patent Dispute With AbbVie BU
Silvergate Capital Corporation (NYSE:SI) acquired Blockchain-Based Payment Network Assets from Diem Association for approximately $170 million. CI
Vieco USA, Inc. completed the acquisition of NextGen Acquisition Corp. II from NextGen Sponsor II LLC and Others in a reverse merger transaction. CI
Sanofi : Sarclisa® (isatuximab) trial is first Phase 3 study to meet primary endpoint of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma PU
The We Company completed the acquisition of BowX Acquisition Corp. from BowX Sponsor, LLC, Blackrock Financial Management Inc., Wellington Management Group LLP, Aristeia Capital, LLC, Millennium Group Management LLC and others in a reverse merger transaction. CI
Transcript : Sachem Capital Corp. - Shareholder/Analyst Call
Vieco USA, Inc. entered into a definitive merger agreement to acquire NextGen Acquisition Corp. II from NextGen Sponsor II LLC and Others for $3.1 billion in a reverse merger transaction. CI
Aquaporin A/S : Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Aquaporin’s shares AQ
Aquaporin A/S : End of Stabilization period AQ
Calliditas Therapeutics : and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe (Form 6-K) PU
Calliditas Therapeutics : and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe AQ
Major shareholder announcement AQ
Sanofi : streamlines Consumer Healthcare portfolio in Europe with divestiture of 16 brands to STADA PU
Danske Bank A/S : Stabilization period begins AQ
Aquaporin A/S : announces the result of its Initial Public Offering AQ
The We Company entered into a non-binding letter of intent to acquire BowX Acquisition Corp. from BowX Sponsor, LLC, Blackrock Financial Management Inc.,Wellington Management Group LLP, Aristeia Capital, LLC, Millennium Group Management LLC and others in a reverse merger transaction for $6.4 billion. CI
Transcript : Sachem Capital Corp. - Shareholder/Analyst Call
Medical Cannabis Legalization Helps Destigmatize Related Products PR
MediPharm Labs : European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs AQ
MediPharm Labs : European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs AQ
MediPharm Labs : European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs AQ
European Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs GL
Sonic Healthcare : Annual Report to shareholdersOpens in a new Window PU
Bausch Health : + LOMB LICENSES EXCLUSIVE RIGHTS FROM STADA AND XBRANE TO A BIOSIMILAR CANDIDATE FOR LUCENTIS IN THE UNITED STATES AND CANADA AQ
Xbrane Biopharma publ : and STADA partner with Bausch + Lomb for commercialization of Xlucane in the United States and Canada AQ
Transcript : Lennar Corporation - Shareholder/Analyst Call
Exclusive: Germany's Stada buys 15 GSK consumer health brands RE
STADA Arzneimittel : to acquire established OTC and food supplement portfolio in the Philippines PU
123NextSee all

Companies (26)

LOTUS BAKERIES NV 8 646 M $
Logo Lotus Bakeries NV

Lotus Bakeries NV, founded in 1932, operates worldwide in the indulgent and natural snacking segment with brands including Lotus®, Biscoff®, nàkd®, TREK®, BEAR®, Kiddylicious®, Peter's Yard®, Dinosaurus®, Peijnenburg® and Annas®. Headquartered in Belgium, ...

MESABI TRUST 232 M $
Logo Mesabi Trust

Mesabi Trust is a royalty trust organized to derive income from an iron mine (the Peter Mitchell Mine) located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range. The Trust is a pass-through entity. It operates in one segment, which is i ...

G2 GOLDFIELDS INC. 200 M $
Logo G2 Goldfields Inc.

G2 Goldfields Inc. is a Canada-based company, which is primarily engaged in the business of acquiring and exploring mineral properties. The Company’s 19,200-acre Oko project is located in the southeastern portion of the Cuyuni Mining District, approxima ...

POST HOLDINGS, INC. 6 445 M $
Logo Post Holdings, Inc.

Post Holdings, Inc. is a consumer-packaged goods holding company. The Company operates through four segments: Post Consumer Brands, Weetabix, Foodservice and Refrigerated Retail. Post Consumer Brands segment includes North American ready-to-eat (RTE) cere ...

GURKTALER AG 25 M $
Logo Gurktaler AG

Gurktaler AG is an Austria-based company engaged in the provision of herbal liquors. The Company principally diversifies its activities into two business areas: operational activities in the field of herbal liquors engaged by the Company's subsidiaries an ...

BILLINGTON HOLDINGS PLC 92 M $
Logo Billington Holdings Plc

Billington Holdings Plc is a United Kingdom-based structural steel and construction safety solutions specialist. The Company's segments include Structural Steelwork and Safety Solutions. The Structural Steelwork segment includes the activities of Billingt ...

RAMP METALS INC. 4 M $
Logo Ramp Metals Inc.

Ramp Metals Inc. is a Canada-based battery and base metal exploration company. The Company is focused on green field exploration and new technologies. The Company has two flagship properties located in northern Saskatchewan and one property in Nye County, ...

AGAVENNY CORPORATION 738 000 $
Logo Agavenny Corporation

Agavenny Corporation is a holding company with portfolio interests primarily operating in the men’s apparel and accessories segment of the fashion industry. The Company will seek to start new businesses and/or acquire businesses or business opportunitie ...

PREMIER INVESTMENTS LIMITED 3 224 M $
Logo Premier Investments Limited

Premier Investments Limited is an Australia-based company, which operates a number of specialty retail fashion chains within the specialty retail fashion markets in Australia, New Zealand, Asia and Europe. The Company also has investments in listed securi ...

PEOPLE'S GARMENT 25 M $
Logo People's Garment

People's Garment Public Company Limited is a Thailand-based company, which is engaged in the manufacturing and distributing ready-made clothes. Its operations are carried on only in Thailand. Its garment production business includes manufacturing menswear ...


123Next

Insiders


Picture Peter Goldschmidt
Peter Goldschmidt

Presently, Peter Goldschmidt occupies the position of Chairman-Executive Board at STADA Arzneimittel AG, Chief Executive Officer of Fougera Pharmaceuticals, Inc. and President of Sandoz, Inc. He is also on the board of Association for Accessible Medicines. He previously held the position of Head-Marketing at Novartis Pharma (Sweeden), Country President at Novartis Healthcare Philippines, Inc., Head-Central & Eastern Europe at Sandoz International GmbH and Head-Sales & Marketing at Novartis Pharmaceuticals. Peter Goldschmidt received a graduate degree and an undergraduate degree from the University of Münster.


Picture Boaz Goldschmidt
Boaz Goldschmidt

Mr. Goldschmidt was the co-founder of Yozma and the core of its management team since inception in January 1993.
Mr. Goldschmidt led many of Yozma's investments in Communications and Internet companies, including E-sim (NASDAQ: ESIM), CommTouch (NASDAQ: CTCH), Telegate (acquired by Terayon Communications, NASDAQ: TERN), HarmonyCom - recently received an investment from Cisco (NASDAQ: CSCO), and Trellis Photonics - recently received investment from Agilent (NYSE:A) and Enron (NYSE: ENE).
Prior to joining Yozma, Goldschmidt gained extensive experience as head of the Royalties Department at the Office of the Chief Scientist.
In this capacity Mr. Goldschmidt evaluated investments in hundreds of high-tech companies primarily in the fields of Communications, Software, and Microelectronics.
Mr.Goldschmidt served on Conduit's BOD and later as Conduit's VP Corp Dev.
He is an active investor and his recent investments include: Javelin Medical, Nova sight, Imvision technologies, Minovia Theraputics, Tingo Medical, Triple jump, Nanorep (Acquired by logmein).
Mr. Goldschmidt holds a BA degree in Economics and an MBA degree from the Hebrew University of Jerusalem.


Picture Sophie Goldschmidt
Sophie Goldschmidt

Sophie Goldschmidt is currently the President & Chief Executive Officer at US Ski & Snowboard Team Foundation.
She is also a Director at Rugby International Marketing LLC, Cain Acquisition Corp., and a Governor at International Tennis Hall of Fame, Inc. Her former positions include Chief Executive Officer at Association of Surfing Professionals International LLC from 2017 to 2020, Non-Executive Director at Youth Sport Trust from 2012 to 2018, Group Managing Director at CSM Sport & Entertainment LLP, Non-Executive Director at PGA European Tour from 2012 to 2018, Vice President-Marketing & Sponsorships at Wta Tour, Inc., and Chief Commercial & Marketing Officer at Rugby Football Union from 2011 to 2016.
She received her undergraduate degree from Baylor University.




Picture Eli Goldschmidt
Eli Goldschmidt

Mr. Eli Goldschmidt is Executive VP-Communications & Regulations at Israel Corp.
Ltd.
He received his graduate degree from Tel-Aviv University.


Picture Mikael Goldschmidt
Mikael Goldschmidt

Mikael Goldschmidt is the founder and CEO of M.
Goldschmidt Capital A since 2007.
He is currently the CEO of Kalypso Ejendomme ApS and Chairman of Inspiration A, Slotshotellet ApS, and Kokkedal Slot ApS.
He is also the Chairman of M.
Goldschmidt Ejendomme.
A since 2005 and MGE Bolig Hillerød P since 2007, and MGE Bolig Hillerød Holding A since 2011.
He previously served as Chairman of Imerco A.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW